Authors:
RASPER DM
VAILLANCOURT JP
HADANO S
HOUTZAGER VM
SEIDEN I
KEEN SLC
TAWA P
XANTHOUDAKIS S
NASIR J
MARTINDALE D
KOOP BF
PETERSON EP
THORNBERRY NA
HUANG JQ
MACPHERSON DP
BLACK SC
HORNUNG F
LENARDO MJ
HAYDEN MR
ROY S
NICHOLSON DW
Citation: Dm. Rasper et al., CELL-DEATH ATTENUATION BY USURPIN, A MAMMALIAN DED-CASPASE HOMOLOG THAT PRECLUDES CASPASE-8 RECRUITMENT AND ACTIVATION BY THE CD-95 (FAS, APO-1) RECEPTOR COMPLEX, Cell death and differentiation, 5(4), 1998, pp. 271-288
Authors:
BLACK SC
BRIDEAU C
CIRINO M
BELLEY M
BOSQUET J
CHAN CC
RODGER IW
Citation: Sc. Black et al., DIFFERENTIAL EFFECT OF A SELECTIVE CYCLOOXYGENASE-2 INHIBITOR VERSUS INDOMETHACIN ON RENAL BLOOD-FLOW IN CONSCIOUS VOLUME-DEPLETED DOGS, Journal of cardiovascular pharmacology, 32(5), 1998, pp. 686-694
Citation: Sc. Black et al., EFFECT OF RAMIPRILAT OR CAPTOPRIL ON MYOCARDIAL INFARCT SIZE - ASSESSMENT IN CANINE MODELS OF ISCHEMIA ALONE AND ISCHEMIA WITH REPERFUSION, Pharmacology, 57(1), 1998, pp. 35-46
Authors:
BLACK SC
HUANG JQ
REZAIEFAR P
RADINOVIC S
EBERHART A
NICHOLSON DW
RODGER IW
Citation: Sc. Black et al., COLOCALIZATION OF THE CYSTEINE PROTEASE CASPASE-3 WITH APOPTOTIC MYOCYTES AFTER IN-VIVO MYOCARDIAL-ISCHEMIA AND REPERFUSION IN THE RAT, Journal of Molecular and Cellular Cardiology, 30(4), 1998, pp. 733-742
Citation: Sc. Black et Iw. Rodger, METHODS FOR STUDYING EXPERIMENTAL MYOCARDIAL ISCHEMIC AND REPERFUSIONINJURY, Journal of pharmacological and toxicological methods, 35(4), 1996, pp. 179-190
Authors:
GRALINSKI MR
BLACK SC
STANCATO LF
KILGORE KS
CAMPAU PA
PARK JL
OZECK MJ
PRATT WB
LUCCHESI BR
Citation: Mr. Gralinski et al., HEAT-STRESS PROTECTS THE PERFUSED RABBIT HEART FROM COMPLEMENT-MEDIATED INJURY, American journal of physiology. Heart and circulatory physiology, 40(2), 1996, pp. 571-578
Authors:
FRIEDRICHS GS
ABREU JN
BLACK SC
CHI LG
LUCCHESI BR
Citation: Gs. Friedrichs et al., 5-HYDROXYDECANOATE FAILS TO ATTENUATE VENTRICULAR-FIBRILLATION IN A CONSCIOUS CANINE MODEL OF SUDDEN CARDIAC DEATH, European journal of pharmacology, 306(1-3), 1996, pp. 99-106
Authors:
FRIEDRICHS GS
BLACK SC
CHI L
MU DX
PEWITT SR
LUCCHESI BR
Citation: Gs. Friedrichs et al., THE KATP CHANNEL ANTAGONIST 5-HYDROXYDECANOATE FAILS TO PROTECT AGAINST VENTRICULAR-FIBRILLATION IN A CONSCIOUS CANINE MODEL OF SUDDEN CARDIAC DEATH, The FASEB journal, 9(3), 1995, pp. 605-605
Authors:
FRIEDRICHS GS
CHI L
GRALINSKI MR
BLACK SC
BASLER GC
MU DX
PEWITT SR
JOHNSON CR
LUCCHESI BR
Citation: Gs. Friedrichs et al., MS-551 PROTECTS AGAINST VENTRICULAR-FIBRILLATION IN A CHRONIC CANINE MODEL OF SUDDEN CARDIAC DEATH, Journal of cardiovascular pharmacology, 25(2), 1995, pp. 314-323
Authors:
BLACK SC
GRALINSKI MR
FRIEDRICHS GS
KILGORE KS
DRISCOLL E
LUCCHESI BR
Citation: Sc. Black et al., CARDIOPROTECTIVE EFFECTS OF HEPARIN OR N-ACETYLHEPARIN IN AN IN-VIVO MODEL OF MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY, Cardiovascular Research, 29(5), 1995, pp. 629-636
Authors:
DRISCOLL EM
BLACK SC
SCHASTEEN CS
WEISS RH
RILEY DP
Citation: Em. Driscoll et al., INHIBITION OF IN-VIVO MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY BY ASYNTHETIC SUPEROXIDE-DISMUTASE (SOD) MIMETIC, The FASEB journal, 8(5), 1994, pp. 10000606-10000606
Authors:
GRALINSKI MR
BLACK SC
KILGORE KS
CHOU AY
DENARDIS M
LUCCHESI BR
Citation: Mr. Gralinski et al., CARDIOPROTECTIVE EFFECTS OF RANOLAZINE (RS-43285) ON ISOLATED RABBIT HEARTS DURING ISCHEMIA-REPERFUSION, The FASEB journal, 8(4), 1994, pp. 10000559-10000559
Authors:
BLACK SC
GRALINSKI MR
FRIEDRICHS GS
KILGORE KS
DRISCOLL EM
LUCCHESI BR
Citation: Sc. Black et al., CARDIOPROTECTIVE EFFECTS OF N-ACETYLHEPARIN (NHEP) IN A CANINE MODEL OF ISCHEMIA AND REPERFUSION INJURY, The FASEB journal, 8(4), 1994, pp. 10000559-10000559
Authors:
BLACK SC
GRALINSKI MR
MCCORMACK JG
DRISCOLL EM
LUCCHESI BR
Citation: Sc. Black et al., EFFECT OF RANOLAZINE ON INFARCT SIZE IN A CANINE MODEL OF REGIONAL MYOCARDIAL ISCHEMIA REPERFUSION/, Journal of cardiovascular pharmacology, 24(6), 1994, pp. 921-928
Authors:
FRIEDRICHS GS
CHI LG
BLACK SC
MANLEY PJ
LUCCHESI BR
Citation: Gs. Friedrichs et al., ANTIARRHYTHMIC AGENT, MS-551, PROTECTS AGAINST PINACIDIL PLUS HYPOXIA-INDUCED VENTRICULAR-FIBRILLATION IN LANGENDORFF-PERFUSED RABBIT ISOLATED HEART, Journal of cardiovascular pharmacology, 23(1), 1994, pp. 120-126
Authors:
BLACK SC
SCHASTEEN CS
WEISS RH
RILEY DP
DRISCOLL EM
LUCCHESI BR
Citation: Sc. Black et al., INHIBITION OF IN-VIVO MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY BY ASYNTHETIC MANGANESE-BASED SUPEROXIDE-DISMUTASE MIMETIC, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 1208-1215
Authors:
GRALINSKI MR
BLACK SC
KILGORE KS
CAMPAU PA
STANCATO LF
PRATT WB
LUCCHESI BR
Citation: Mr. Gralinski et al., IN-VIVO HEAT-STRESS PROTECTS AGAINST COMPLEMENT-MEDIATED INJURY IN THE ISOLATED RABBIT HEART, Circulation, 90(4), 1994, pp. 537-537
Authors:
GRALINSKI MR
BLACK SC
KILGORE KS
CAMPAU PA
STANCATO LF
PRATT WB
LUCCHESI BR
Citation: Mr. Gralinski et al., IN-VIVO HEAT-STRESS PROTECTS AGAINST COMPLEMENT-MEDIATED INJURY IN THE ISOLATED RABBIT HEART, Circulation, 90(4), 1994, pp. 537-537
Authors:
GRALINSKI MR
BLACK SC
KILGORE KS
CHOU AY
MCCORMACK JG
LUCCHESI BR
Citation: Mr. Gralinski et al., CARDIOPROTECTIVE EFFECTS OF RANOLAZINE (RS-43285) IN THE ISOLATED-PERFUSED RABBIT HEART, Cardiovascular Research, 28(8), 1994, pp. 1231-1237
Citation: Sc. Black et Br. Lucchesi, POTASSIUM CHANNEL OPENERS ARE LIKELY TO BE PROARRHYTHMIC IN THE DISEASED HUMAN HEART, Cardiovascular Research, 28(6), 1994, pp. 923-924
Citation: L. Chi et al., CONTROVERSY ON DRUGS AFFECTING ATP-SENSITIVE POTASSIUM CHANNELIN ISCHEMIC-HEART-DISEASE, Cardiovascular Research, 28(1), 1994, pp. 136-137
Authors:
TSCHOPP JF
DRISCOLL EM
MU DX
BLACK SC
PIERSCHBACHER MD
LUCCHESI BR
Citation: Jf. Tschopp et al., INHIBITION OF CORONARY-ARTERY REOCCLUSION AFTER THROMBOLYSIS WITH AN RGD-CONTAINING PEPTIDE WITH NO SIGNIFICANT EFFECT ON BLEEDING-TIME, Coronary artery disease, 4(9), 1993, pp. 809-817
Citation: Sc. Black et al., PROTECTION AGAINST PROGRAMMED ELECTRICAL STIMULATION-INDUCED VENTRICULAR-TACHYCARDIA AND SUDDEN CARDIAC DEATH BY NE-10064, A CLASS-III ANTIARRHYTHMIC DRUG, Journal of cardiovascular pharmacology, 22(6), 1993, pp. 810-818